Skip to content
DiviCompasshome

Stock research

Nektar Therapeutics (NKTR) dividends

NKTR on Nasdaq, Health Care

$34.42 -4.15% on previous close. Close on 18 Nov 2026, in USD

Sign in to get an email when it declares a dividend.

Trailing yield—Regular dividends, last 12 months
Forward yield (estimate)—No estimate
Next 12 months per share—Irregular
5-year dividend growth—Not enough history
Payout ratio—No filing imported
Free cash flow cover—Health score needs more data

Nektar Therapeutics dividend: key facts

Next dividend None expected In the next 12 months
How often Irregular No regular pattern
Listed onNasdaq

Own Nektar Therapeutics? See exactly what it will pay you

Add your shares to a free DiviCompass portfolio to see your next NKTR dividend in your own money, every payment month by month, and an email when it declares. Free for up to 10 holdings, no card needed.

Price history

End-of-day closes on Nasdaq in USD. Dots mark ex-dividend dates.

Dividend history

Declared dividends. Special dividends are marked and excluded from yield and forecasts.

No dividends imported for this company.It may not pay a dividend, or its dividends have not been added yet.

Reported financials

Annual figures from filings, converted to units.

No annual filings imported yet.Payout ratio and cash cover appear once they are.

Results, reports and dividend announcements

About Nektar Therapeutics

Nektar Therapeutics is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances, which improves drug characteristics like retention and solubility. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, etc. The company developed the world's first inhalable non-injectable insulin, Exubera, which was awarded as the bronze award by Wall Street Journal for its technological breakthrough.

From Wikipedia, CC BY-SA 4.0.

Next 12 months

No dividends expected from the data available.

Estimate confidence: None

Company news

Insufficient verified data for a financial-health score

Dividend data and price last updated 18 Nov 2026.